Ordreindtastning
Denmark
ContactUsLinkComponent
 
EasySep™ Mouse TIL (CD45) Positive Selection Kit
  STMC100-0350
undefined
EasySep™ Mouse TIL (CD45) Positive Selection Kit
  STMC100-0350

 

  • Beskrivelse:
    EasySep™ Mouse TIL (CD45) positive selection kit, 1×10⁹ cells
  • Environmentally Preferable:
  • Pakn:
    1 KIT

 

 

Immunomagnetic positive selection of mouse CD45+ TILs from single-cell suspensions of solid tumors.

  • Fast, easy to use, and column-free
  • Optimised for tumors and tissue samples with a low CD45 start frequency
  • Flexible protocols for higher purity or recovery

The EasySep™ Mouse TIL (CD45) Positive Selection Kit is designed to isolate highly purified CD45+ tumor infiltrating leukocytes (TILs) by immunomagnetic positive selection. This kit has been optimised for use on single-cell suspensions of solid mouse tumors with a low CD45+ start cell frequency, including tumors induced by implantation of 4T1, B16-F10, and CT26.WT cell lines into syngeneic mice. Due to the heterogeneity of mouse tumors, this kit may require optimisation.

This kit targets CD45+ cells for positive selection with antibodies recognising the CD45 surface marker. Desired cells are labeled with antibodies and magnetic particles, and separated without columns using an EasySep™ magnet. Unwanted cells are simply poured off, while desired cells remain in the tube. Isolated cells are immediately available for downstream applications such as flow cytometry, culture, and cell-based experiments.

 : Product Restrictions: (i) Customer shall not make products or any portion of them, in any way, shape or form, including as a component of another product available for the purpose of further resale or alter or remove the Product label and the Supplier’s mark of origin without express written permission of Supplier; and (ii) Customer is familiar with Supplier’s restrictions on the use of the Products and shall use the Products in compliance with such restrictions and the applicable Supplier Product Information sheet (collectively, the ‘Product Restrictions’).